Helmut Thomas

LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada.

Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO.

Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG.

Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas.